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ABSTRACT 
The cost of biopolymer production is one of the most important factor restricting the industrial application of Polyhydroxybutyrate (PHB). The 
main aim of this present study is to explore suitable low-cost novel substrate for PHB production. In this study, giant reed grass (GRG) biomass 
was pretreated with different concentration of NaOH (1-3%) at various conditions like room temperature, microwave irradiation high 
temperature and pressure (HTP). Among these three conditions, at the HTP pretreatment with 2% NaOH, the maximum fermentable glucose of 
79.32% was obtained after removal of llignin by SC/AA treatment. Further, this pretreatment condition was used for hydrolysate preparation 
for PHB biosynthesis using B. subtilis RNM. Under optimized condition, the maximum PHB of 46.21±0.2 gL-1 was obtained from GRG 
hydrolysate. This result indicates that the GRG hydrolysate could be a novel low-cost substrate for PHB biosynthesis. This is the first attempt we 
made to use GRG hydrolysate as feedstock for PHB biosynthesis. Moreover, the produced PHB was characterized by 1H NMR, FTIR and thermal 
amalysis (DSC and TGA) techniques. The characterized results were very similar to characters of commercial PHB. Further, t he produced PHB 
was used for doxorubicin - PHB microparticles preparation with 93.21±0.15 % of encapsulation efficiency and found its anticancer drug 
delivery efficiency as 98%. Hence, this study demonstrates that the PHB biosynthesized from GRG hydrolysate could be a best b iodegradable 
polymer for anticancer drug doxorubicin encapsulation and delivery. 
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INTRODUCTION 
In recent years, disposal of synthetic plastic waste is a big 
ecotechnological problem. This could be solved by the 
development of biodegradable plastics using principles of 
green chemistry.  Green chemistry is playing an important 
role in the development of eco-friendly materials for the 
next generation. One of such development is producing 
biodegradable polymers from renewable resources, which 
does not compete with food crops. Polyhydroxyalkanoates 
(PHAs) is a biodegradable linear polyesteric biological 
macromolecules which occurs in several microorganisms in 
the form of intracellular storage granules in response to 
nutritional and environmental conditions. 
Polyhydroxybutyrate (PHB) is a type of PHAs and its many 
material properties were similar to various synthetic 
polymers like polypropylene. However, the PHB differ from 
synthetic polymers in properties biodegradable, 
biocompatible and can be derived from renewable sources. 
These make them useful for extensive applications and 
future commercial large-scale production of PHB that can 
replace synthetic plastics, which currently obtained from 
petroleum bases1. 
Production cost is a major problem for PHB 
commercialization because it totally depends on the 
microorganisms, substrates (carbon source), the nutritional 
parameters, physical parameters and the downstream 
process such as recovery and purification. Currently, much 
efforts have been taken to reduce the PHB production cost 
through the strategies viz microbial strain development, 
optimizing fermentation process parameters and recovery 
processes2,3. The carbon source has the major influence over 
the (PHB) production cost, rummage around for inexpensive 
carbon sources has become one of the significant research in 
the PHB production4. Carbon rich wastes are attractive 
candidate since they have some of the desired 
characteristics namely low prices and high availability. A 
wide variety of substrates such as waste glycerol, whey, 
lignocellulosic materials and wastewater has been used with 
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different microorganisms to improve the yields of PHB 
production and also to avoid the environmental disposal 
problems5,6. 
The value-added products from feedstock of carbohydrate 
fractions present lignocellulosics is a promising strategy for 
sustainable bioprocesses. However, the necessity of 
obtaining monomeric fermentable sugars from 
carbohydrates represents an obstacle that still affects the 
economic viability of bioprocesses, especially due to the high 
recalcitrance of carbohydrate present biomass to 
pretreatment by chemicals or enzymes. A chemical 
pretreatment is an interesting approach of hemicellulose 
hydrolysis, resulting in a fermentable sugar enriched 
hydrolysate. Chemical pretreatment processes for 
hydrolysate preparation from hemicellulose by using dilute 
acid or alkaline solutions are commonly used and they 
further enhance enzymatic hydrolysis of the remaining 
cellulose. However, the chemical pretreatment requires 
neutralization and removal the chemical from hydrolysate to 
avoid negative effects on downstream steps7,8. Besides, 
during the pretreatment the phenolic and furan compound 
tends to become as a toxic compounds to microorganisms 
that are involving in bioprocesses9. Thus, challenges in the 
chemical pretreatment processes include preparing less 
toxic hydrolysates for microorganisms and less corrosive to 
process equipment.  Therefore, optimization of chemical 
pretreatment of biomass are necessary 8,10,11. 
Cost of biopolymer production is one of the most important 
factors restricting the industrial application of PHB. Thus, 
the main aim of this present study is to explore the 
feasibility of PHB biosynthesis which was evaluated with 
delignified giant reed grass hydrolysate as substrate and 
mutant bacterial strain as a biocatalyst under aerobic 
microenvironment. Next, the classical method of 
optimization was used for optimize the various physical 
parameters for enhancing PHB production from hydrolysate 
of giant reed grass. Further, the anticancer drug 
encapsulation efficiency and in vitro drug release was also 
studied to enhance the produced PHB application in 
pharmaceutical field. This is the first report to our 
knowledge claiming giant reed grass hydrolysate as a 
substrate for production of PHB. 
MATERIALS AND METHODS 
Materials and Chemicals 
Giant reed grass (Arundo donax L.) sample was collected 
directly from a riverbank of Palaur river Kanchipuram, 
Tamil Nadu, India. The leaves of the sample plant were 
separated from the stems and then thoroughly washed with 
water to remove sand and other impurities. Then the sample 
was chopped into small pieces (size 1 mm) using lab scale 
blender and dried at 50oC for 12 h12. The dried sample was 
ground and stored in the fridge until use. 
All chemicals used in the present study was highest purity or 
analytical grade (Hi-media Pvt. Ltd. Mumbai, and SRL India), 
obtained from recognized chemical supplier. The anticancer 
drug doxorubicin purchased from local medical shop.  
Alkaline Pretreatment and delignification of giant reed 
grass (GRG) biomass 
GRG sample was treated with different concentration of 
NaOH range from 1-3% at room temperature, microwave 
irradiation (2450MHz) (MI) and high temperature and 
pressure (HTP). The pretreated samples were washed with 
distilled water and then dried at 50–60oC for 24 h. Then the 
samples were subjected to delignification by sodium 
chlorite/acetic acid (SC/AA) method13. Finally, the samples 
were washed thoroughly with tap water to remove traces of 
chemicals used during the treatments and dried at 50–60oC 
before using for biosynthesis of PHB. Monosaccharide 
concentrations of sample each pretreated method was 
estimated. Based on the monosaccharide yield the best 
pretreatment condition was used for further study. 
Bacterial strain and Maintenance 
The feasibility of PHB biosynthesis was evaluated with GRG 
hydrolysate as substrate and mutant bacterial strain as a 
biocatalyst under aerobic microenvironment. In the present 
study, the mutant bacterium Bacillus subtilis RNM was used 
for PHB production. Before using, the bacterial strain was 
maintained in nutrient agar (Peptone 5 gL-1, Beef extract 3 
gL-1, Sodium Chloride 5 gL-1 and Agar 15 gL-1) slant and 
stored at 4oC for further uses. The cultures were revived 
after every month14. 
Biosynthesis PHB using GRG hydrolysate  
The batch experiments were carried out in 250 mL shaking 
flasks using 100 mL of nitrogen limited (0.25 g/L NH4Cl) 
mineral salt medium (MSM containing: Na2HPO4 (6 gL-1), 
KH2PO4 (3 gL-1), NaCl (0.5 g L-1), CaCl2.2H2O (1 M L-1), 
MnSO47.H2O (1 M L-1), FeCl2 (0.01g L-1), CuSO4.5H2O (0.01g 
L-1), ZnSO4.7H2O(0.1g L-1), MgSO47.H2O (1 M L-1)) with 
maximum sugar contained GRG hydrolysate. Then flasks 
were inoculated with 1% of overnight culture of B. subtilis 
RNM and grown for 72 h in a rotary shaker at 30 0C and 200 
rpm. Triplicate flasks experiments were carried out for each 
study. End of the experiment the samples were withdrawn 
and the biomass was separated by centrifugation at 
14,000×g at for 15 min. The biomass was used to extract and 
estimated the PHB. The optimum concentration of GRG 
hydrolysate was used for further optimization of PHB 
biosynthesis with the following conditions. The effect of 
different pH (4.5 to 9), temperature (30 to 60oC) and 
agitation speed (100 to 250 rpm) on PHB biosynthesis by 
B.subtilis RNM was studied by classical method of 
optimization. All the experiments were carried out in 
triplicate to check the reproducibility.  
Analytical methods 
Estimation of total reducing sugars and HPLC analysis of 
monosaccharide 
The sugar concentration of hydrolysates and culture 
supernatant was estimated by Dinitrosalicylic (DNS) acid 
method15. HPLC analysis of monosaccharide composition of 
hydrolysate was determined by Li et al16. Before HPLC 
analysis, 1-phenyl-3-methyl-5-pyrazolone (PMP) 
derivatization of GRG hydrolysate was carried out by the 
method of Zhang et al17. Then the analysis was carried out 
with an HPLC using a Capcell Pak C18 MG column (3 mm i.d. x 
250 mm, 5 µm, Shiseido, Japan) at 30oC. Elution was with 
sodium phosphate buffer (40 mM, pH 8.0)/acetonitrile 
(79:21, v/v) at 0.5 mL min-1. Detection was at 245 nm. 
Determination of cell dry weight (CDW) 
The B. subtilis RNM cells were harvested by centrifugation at 
14,000 rpm for 10 min. The pellet was collected and washed 
with distilled and frozen overnight at -20oC. Then the cells 
weight was determined and the CDW was expressed in gL-1. 
Extraction and estimation  
PHB was extracted by the method of Koller et al18. B. subtilis 
RNM biomass was collected by centrifugation at 14,000 rpm 
for 10 min and the hydrophobic residual oil was removed 
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from biomass by treated with 5 ml of cold water and 2 ml of 
cold hexane. Then the biomass was dried in oven until 
getting a constant weight. About 3 g of dried biomass was 
used for Soxhlet extraction using chloroform as solvent. 5 
mg of extracted PHB was redissolved in 5 ml of chloroform 
in water bath at 90°C for 25 min to remove the impurities 
and then filtered the sample using Whatman No.1 filter 
paper. Finally, chloroform was evaporated by taking the 
sample sterile glass petri plate and then stored at 4°C until 
further use 19. The extracted PHB estimated by Law and 
Slepecky20 method and used for further characterization. 
Differential scanning calorimetry (DSC) analysis 
The thermal transitions of PHB were measured using 
differential scanning calorimeter (TA Instruments Q-100, 
USA). The measurement was done over a temperature range 
from -20 to 180◦C at a heating rate of 10oC min-1 under 
nitrogen atmosphere (50 ml min-1). The sample (2 mg) was 
in an aluminum pan and heated temperature range from -20 
to 180oC at a scanning rate of 10oC min-1 under nitrogen 
atmosphere (50 ml min-1).  The thermal property of the 
sample was analyzed from the second heating round DSC 
curve. Glass transition (Tg) temperature was used as the 
midpoint of sample heat capacity change. Melting 
temperature (Tm) was estimated from DSC endothermal 
peaks. The maximum peak temperature was taken as Tm. 
Thermogravimetric (TGA) analysis 
TGA was performed on a Perkin-Elmer TGA 4000. The 
temperature was ramped at a heating rate of 10oC min-1 
under nitrogen flow rate of 20 mL min-1 to a temperature 
well above the degradation temperature of the polymers 
(500oC) 
Fourier transforms infrared spectroscopy (FTIR) 
4 mg of PHB was mixed thoroughly with KBr (Spectroscopic 
grade) and then dried at 100oC for 4 h. IR spectra of PHB was 
recorded and analyzed using a single beam Perkin Elmer 
(Spectrum BX series, Sweden), with the scan in the range 
from 4000–500 cm-1; number of scans, 16 and resolution, 4.0 
cm-1. 
NMR analysis of PHB  
The 1H NMR spectra of sample (20 mg mL−1) was recorded at 
room temperature in CDCl3 using Bruker AV 400 NMR 
spectrometer (Bruker, Swiss) and determined the monomer 
composition of PHB using Kato et al., 21 method. The internal 
standard was Tetramethylsilane.  
Preparation of Doxorubicin - PHB microparticles 
PHB produced from GRG hyrdolysate by B. subtilis RNM was 
used to study the drug encapsulation efficiency and 
releasing efficiency. Anticancer drug doxorubicin - PHB 
microparticles were prepared by the oil-in-water emulsion-
solvent evaporation method22 with minor modification. A 
500 mg of PHB obtained from GRG hydrolysate and the 400 
mg of drug (200 mL) were dissolved in 5 mL of 
dichloromethane (DCM) and then emulsified in 200 mL of an 
aqueous phase containing 0.15 % (m/v) of poly (vinyl 
alcohol) [PVA] as stabilizer. Finally, the organic solvent 
(DCM) was evaporated by continuous stirring at 700 rpm, at 
room temperature.  The doxorubicin loaded PHB 
microparticles were washed with distilled water followed by 
dried and stored under vacuum at room temperature. This 
preparation was repeated minimum three to four times to 
establish the reproducibility of this microparticles 
preparation. 
Determination of drug encapsulation efficiency  
The encapsulation efficiency of doxorubicin in PHB 
microparticles was estimated using UV-Visible 
spectrophotometer (Shimadzu-1700) at 266 nm by the 
method of Bazzo et al22. The microparticles drug content was 
then estimated. The loading efficiency was obtained using 
the following equation 
Encapsulation 
efficiency (%) = 
Drug found in 
microparticles 
X 100 
Drug initially added to 
the formulation 
 
In vitro release profile of Doxorubicin - PHB 
microparticles 
In vitro release studies of a doxorubicin loaded PHB 
nanomedicine formulation were carried out by dialysis bag 
diffusion technique with phosphate buffer solution (PBS) pH 
7.4 at 37 ± 0.5 °C under constant stirring (100 rpm). A 10 mg 
of doxorubicin - PHB microparticles was enclosed in the 
dialysis bag (Dialysis membrane, molecular weight cut off of 
12000-14000 Da (Himedia, Mumbai, India) and then 
incubated in 200 mL of PBS. At pre- selected time (0.5 to 72 
h), 2 mL of sample was withdrawn and the drug released 
was measured by UV-Vis spectrophotometry, at 266 nm.  
Statistical analysis 
The results of all the experiments were presented as the 
mean ± standard deviation (SD) values of three independent 
replicates. The standard deviation did not exceed 5% of the 
average values. The one-way analysis of variance (ANOVA) 
also done for the obtained data using MINITAB 15 software 
at the significant level of p ≤0.05. 
RESULTS AND DISCUSSION 
Optimization of alkaline pretreatment for GRG 
hydrolysate preparation   
Effect of different concentration of NaOH on pretreatment of 
GRG biomass at RT, MI and HTP was studied. After the 
pretreatment by each method, the hydrolysates were 
subjected to delignification treatment using the SC/AA. 
When increasing the NaOH concentration from 1% to 2% the 
amount of total reducing sugar (TRS) yield was increased. 
However, on further increase in the NaOH concentrations 
there was no changes in the yield of TRS. This result 
indicates that the NaOH concentration of 2% was the 
optimum level for pretreatment of GRG biomass, whereas 
the influences of conditions such as RT, MI and HTP on yield 
of TRS differ from each other. Because, in this study, the 
highest TRS of 416.82±0.04 mg g-1 and the lowest TRS 
concentration of 211.33±04 mg g-1 was obtained from GRG 
biomass after lignin removal by HTP and TR condition 
respectively (Table 1). At MI condition, the maximum TRS 
concentration of 338.66±0.03 mg g-1 was obtained after 
lignin removal from GRG biomass.  
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Table 1. Effect of different pre-treatment conditions on 
yield of total reducing sugars 
NaOH Concentration 
(%) 
Total reducing sugar        (mg 
g-1 w/w) at 
RT MI HTP 
Control 180.2 281.2 384.21 
1.0 200.2 320.12 408.21 
1.5 210.32 334.25 410.32 
2.0 211.32 338.66 416.82 
2.5 211.33 338.62 416.86 
3.0 211.45 338.63 416.89 
 
Monosaccharide concentrations of lignin removed 
hydrolysate 
The compositional analysis of different hydrolysates 
prepared from GRG biomass showed in the Table 2, it 
contains predominantly glucose and xylose but it also 
contained significant amount of arabinose and mannose. 
However, the yield of monosaccharides was high in the 
hydrolysate, which was obtained from GRG biomass by HTP 
pretreatment with 2% NaOH. 
 
Table 2. Monosaccharide concentrations (%) of lignin 
removed hydrolysate obtained from GRG biomass after 
different pretreatment with 2% NaOH. Compositional 
analysis of hydrolysates was carried out by HPLC.  
Treatment 
condition 
Monosaccharide Composition (%) 
Glucose Xylose Arabinose Mannose 
RT 71.24 24.31 7.33 1.95 
MI 77.11 20.41 9.41 2.45 
HTP 79.32 21.32 10.21 2.34 
 
Selection of hydrolysate for PHB biosynthesis  
The hydrolysates prepared from GRG biomass by all these 
three conditions (RT, MI and HTP) were checked its 
suitability for PHB biosynthesis using B. subtilis RNM. As 
shown in the Figure 1, the maximum PHB of 33.05±1.0 gL-1 
and 34.25±0.43 gL-1 was obtained from hydrolysates 
prepared with 2% NaOH at MI and HTP conditions 
respectively. This yield ~1.8 fold higher than the PHB 
obtained from hydrolysate prepared with 2% NaOH at RT. 
However, the maximum PHB (34.25±0.43 gL-1) production 
was observed in the GRG hydrolysate prepared with 2% 
NaOH at HTP. The bacterium B. subtilis RNM used in the 
present study was metabolically versatile because it utilized 
all the sugars of this hydrolysate effectively for growth and 
PHB production. Hence, this condition of pretreatment was 
found to be an optimum pretreatment condition for 
hydrolysate preparation from GRG biomass. Further, this 
pretreatment condition was used throughout this study for 
hydrolysate preparation. This study demonstrates that the 
combined physicochemical pretreatment is the best method 
for extracting TRS for various applications. A critical and 
important feature of PHB production process is the 
assimilation and utilization of these sugars by 
microorganisms. Generally, the bacterial strains have the 
ability to produce biodegradable polymers from different 
organic substrates23,24. Based on the experiment outcomes, 
the GRG hydrolysate prepared by HTP pretreatment with 
2% NaOH was considered as best feedstock for maximum 
PHB biosynthesis using B. subtilis RNM. 
 
 
Figure 1. Effect of hydrolysate prepared by different pre-
treatment conditions on the biosynthesis of PHB using B. 
subtilis RNM 
Effect of pH on biosynthesis of PHB  
The effect of medium initial pH on the biosynthesis of PHB 
from GRG hydrolysate using B. subtilis RNM was evaluated 
with different pH range from 4.5 to 9 with an increment of 
0.5 pH. The production medium pH conditions were 
maintained using 1N NaOH/HCl. As shown in the Figure 2, 
the maximum PHB production was observed between the 
pH 6.5 to 7.5, however the highest PHB of 43.22±0.42 gL-1 
was obtained at pH 7.0. The pH below 6.5 and pH above 7.5 
were severely affected the growth of B. subtilis RNM, since 
the PHB yield was decreased. In the current study, pH 7 was 
found to be an optimum pH, which is similar to the finding of 
Kulpreecha et al25 who obtained the maximum PHB 
production by new isolate B. megaterium at pH 7.0.  
 
Figure 2. Effect of pH on biosynthesis of PHB from GRG 
hydrolysate 
Effect of incubation temperature on biosynthesis of PHB  
Effect of the incubation temperature on biosynthesis of PHB 
from GRG hydrolysate using B. subtilis RNM was studied. The 
cultures were maintained at different temperature range 
from 30°C to 60°C with an increment of 5°C. As shown in the 
Figure 3, the maximum 39.35±0.33 gL-1 of PHB production 
was obtained from hydrolysate using B. subtilis RNM at 35°C. 
This temperature was found to be the optimum temperature 
for enhancing the PHB production from GRG hydrolysate by 
B. subtilis RNM. Further, increase in the incubation 
temperature is unfavourable for the growth of B. subtilis 
RNM, hence decreases the PHB production. The correlation 
value of 0.963 (P<0.001) was found for biomass and PHB 
production. This suggests that the biomass and PHB are 
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interdependent. Similar correlation values were found for 
the biomass and temperature, therefore these two is in 
correlation. The result suggesting that the temperature 
above 35°C do not support the growth of B. subtilis RNM. 
 
Figure 3. Effect of temperature on biosynthesis of PHB 
from GRG hydrolysate 
Effect of agitation speed on biosynthesis of PHB 
Effect of agitation speed on the biosynthesis of PHB from 
hydrolysate using was evaluated by varying the culture 
agitation speed from 100 to 300 rpm with an increment of 
50 rpm at optimum pH 7.0 and temperature 35oC. When 
increasing the agitation speed from 100 to 150 rpm there is 
increase in the PHB production (Figure 4), but further 
increase in the speed there was no increment in the PHB 
production because the excessive shear force developed at 
agitation speed >150rpm.  
 
Figure 4. Effect of agitation speed on biosynthesis of PHB 
from GRG hydrolysate 
 
Characterization of PHB obtained from GRG hydrolysate 
1H NMR characterization  
The 1H NMR spectrum of PHB was obtained with CDCl3 
solution. In Figure 5, methyl protons (-CH3) appear to have a 
single resonance at 1.5 ppm, methylene protons (-CH2) 
appear to have a multiplet resonance at 2.45 ppm, methine 
proton (-CH) of bacterial polyhydroxybutyrate also has a 
multiplet resonance at 5.32 ppm. The 1H NMR spectra 
implied that the PHB contains two monomeric units HB and 
HV. 
 
 
Figure 5. 1H NMR spectrum of PHB biosynthesized from GRG hydrolysate 
 
FTIR spectroscopy analysis 
The PHB extracted from GRG hydrolysate grown B. subtilis 
RNM was resembled with commercial PHB because the PHB 
marker absorption peak 1731.2 cm-1 was obtained which is 
for characteristic of carbonyl ester (RC=O). Similarly the 
other absorption peaks in the Figure 6, 3416.20 cm-1,  
2921.80 cm-1, 2634.50 cm-1, 1414.10 cm-1 and 1192.80 cm-1 
were indicative of the presence of  hydroxyl group26 (Ma et 
al., 2009), asymmetric methyl group, CH2 group,  CH3 group27 
and C-O group in the polymer chain of extracted PHB which 
is similar to the FTIR absorption peak of commercial PHB.
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Figure 6. FTIR spectrum of PHB biosynthesized from GRG hydrolysate 
 
Thermal analyses 
Thermal properties of polymer such as Tg and Tm are crucial 
for polymer processing. The Tm of the present study PHB 
was found to be 171.02 oC (Figure 7). Previous reports on Tm 
of different microbial PHB extracted under different 
extraction condition were range from 171–180 oC 28,29,30,31, 
which is in conformity with this finding. Figure 8, 
represented TGA profile of PHB produced from GRG 
hydrolysate. A rapid thermal degradation was observed 
between 249 oC and 280 oC with a peak at 275 oC. TGA profile 
of PHB obtained from GRG hydrolysate by B. subtilis RNM 
showed that the thermal stability with complete degradation 
occurring at 275 oC, which is above the melting temperature 
of 179.5 oC of the pure PHB32. The difference between 
decomposition and Tm of produced PHB was high enough to 
permit for further processing. The PHB obtained from B. 
subtilis RNM could be used for various biomedical 
applications.
 
 
Figure 7. DSC of PHB biosynthesized from GRG hydrolysate 
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Figure 8 TGA of PHB biosynthesized from GRG hydrolysate 
 
Preparation and in vitro release profile of Doxorubicin - 
PHB microparticles 
Doxorubicin is well known anticancer chemotherapy drug 
and used for different kinds of cancers like Breast cancer, 
gastric cancer, liver cancer, ovarian cancer, uterine sarcoma 
etc.  One of the main side effect of this drug is causes heart 
failure. Doxorubicin is directly administered into the 
coronary vessels to minimize systemic side effects such as 
alopecia, weight loss, colitis, and bone marrow 
suppression33. In this study, doxorubicin - PHB 
microparticles were successfully prepared and found 
93.21±0.15% as encapsulation efficiency of drug 
doxorubicin in PHB microparticles. Generally, drug 
entrapment efficiency in polymers or polymer matrix 
completely depends on the nature of polymers, solid-state 
drug solubility in the polymers and end functional groups 
(ester or carboxyl)34,35,36,37.  
 
Figure 8. In vitro release profile of doxorubicin from 
PHB microparticles 
Further, in vitro release studies of a doxorubicin loaded PHB 
nanomedicine formulation were carried out by dialysis bag 
diffusion technique. As shown in the Figure 8, after 24 h, 
98% of the encapsulated doxorubicin was released from the 
microparticles. The PHB used for this study, was 
biosynthesized from GRG hydrolysate. These results indicate 
that the PHB biosynthesized from GRG hydrolysate using B. 
subtilis RNM, could be a best biodegradable polymer for drug 
encapsulation and delivery. 
CONCLUSION 
The HTP pretreatment with 2% NaOH was very effective to 
convert the GRG biomass into fermentable sugar for PHB 
production because at this condition the maximum glucose 
of 79.32% was obtained after lignin removed by SC/AA 
treatment. The PHB yield increased from 34.25±0.43 gL-1 to 
46.21±0.2 gL-1 when B. subtilis RNM grown under optimized 
condition using GRG hydrolysate as low cost PHB 
biosynthesis medium. This study suggests using the GRG in 
substitution for commercial medium, reducing PHB 
production costs and increasing PHB yield. Moreover, the 1H 
NMR and FTIR characterization of the PHB biosynthesized 
from GRG hydrolysate using B. subtilis RNM, results revealed 
that the PHB was similar to the commercial PHB. Besides the 
thermal analysis Tg and Tm also results were also similar to 
the commercial PHB. The produced PHB have 93.21±0.15% 
of anticancer drug doxorubicin encapsulation efficiency in 
PHB microparticles and in vitro condition, 98% of the 
encapsulated doxorubicin releasing efficiency. Hence, the 
PHB biosynthesized from GRG hydrolysate using B. subtilis 
RNM, could be a best biodegradable polymer for anticancer 
drug encapsulation and delivery. 
REFERENCES 
1. Verlinden RAJ, Hill DJ, Kenward MA, Williams CD, Radecka I, 
Bacterial synthesis of biodegradable polyhydroxy 
alkanoates, Journal of Applied Microbiology, 2007; 102:1437-
1449. 
2. Gurieff N, Lant P, Comparative life cycle assessment and 
financial analysis of mixed culture polyhydroxyalkanoates 
production. Bioresource Technology, 2007; 98:3393-3403. 
3. Yu PH, Chua H, Huang AL, Lo W, Chen G-Q, Conversion of food 
industrial wastes into bioplastics. Applied Biochemistry and 
Biotechnology, 1998; 70:603-614.  
Revathi et al                                                                                                               Journal of Drug Delivery & Therapeutics. 2019; 9(4-s):8-15 
ISSN: 2250-1177                                                                                  [15]                                                                                 CODEN (USA): JDDTAO 
4. Nath A, Dixit M, Bandiya A, Chavda S, Desai AJ, Enhanced PHB 
production and scale up studies using cheese whey in fed 
batch culture of Methylobacterium sp. ZP24. Bioresource 
Technology, 2008; 99: 5749-5755. 
5. Naranjo JM, Posada JA, Higuita JC, Cardona CA, Valorization of 
glycerol through the production of biopolymers: The PHB case 
using Bacillus megaterium. Bioresource. Technology, 
2013;133:38-44 
6. Gahlawat G, Soni SK, Valorization of waste glycerol for the 
production of poly (3-hydroxybutyrate) and poly (3-
hydroxybutyrate-co-3-hydroxyvalerate) copolymer by 
Cupriavidus necator and extraction in a sustainable manner, 
Bioresource Technology, 2017; 243: 492-501. 
7. Foust TD, Aden A, Dutta A, Phillips S, An economic and 
environmental comparison of a biochemical and a 
thermochemical lignocellulosic ethanol conversion processes, 
Cellulose, 2006; 16:547-565.  
8. Zhang T, Kumar R, Wyman CE,Sugar yields from dilute oxalic 
acid pre-treatment of maple wood compared to those with 
other dilute acids and hot water, Carbohydrate Polymers, 
2013; 92(1): 334-344. 
9. Santos JC, Marton JM, Felipe MGA, Continuous system of 
combined columns of ion exchange resins and activated 
charcoal as a new approach for the removal of toxics from 
sugar cane bagasse hemicellulosic hydrolysate, Industrial & 
Engineering Chemistry Research, 2014; 53(42): 16494-
16501.  
10. Mtui GYS, Oxalic acid pretreatment, fungal enzymatic 
saccharification and fermentation of maize residues to 
ethanol, African Journal of Biotechnology, 2012; 11(4): 843-
851.  
11. Scordia D, Cosentino SL, Jeffries TW, Effectiveness of dilute 
oxalic acid pre-treatment of Miscanthus xgiganteus biomass 
for ethanol production, Biomass Bioenergy,  2013; 59: 540-
548. 
12. Davis R, Kataria R, Cerrone F, Woods T, Kenny S, O’Donovan A, 
Guzik M,  Shaikh H, Duane G, Gupta VK, Tuohy MG, Padamatti 
RB, Casey E, O’Connor KE, Conversion of grass biomass into 
fermentable sugars and its utilization for medium chain 
length polyhydroxyalkanoate (mcl-PHA) production by 
Pseudomonas strains, Bioresource Technology, 2013; 150: 
202-209. 
13. Han JS, Rowell JS, Chemical composition of fibers. In: Rowell, 
R.M., Young, R.A., Rowell, J.K. (Eds.), Chemical Composition of 
Fibers, Paper Composites from Agro-based Resources. CRC 
Lewis Publisher, New York, 1997; pp. 83–134.  
14. Borman AM, Szekely A, Campbell CK, Johnson EM, Evaluation 
of the viability of pathogenic filamentous fungi after 
prolonged storage in sterile water and review of recent 
published studies on storage methods. Mycopathologia, 2006;, 
161: 361-368. 
15. Miller GL, Use of dinitrosalicylic acid reagent for 
determination of reducing sugar. Analytical Chemistry, 1959; 
31: 426-428.  
16. Li H, Long C, Zhou J, Liu J, Wu X, Long M, Rapid analysis of 
mono-saccharides and oligo-saccharides in hydrolysates of 
lignocellulosic biomass by HPLC, Biotechnology Letter, 2013; 
35:1405–1409.  
17. Zhang LY, Xu J, Zhang LH, Zhang WB, Zhang YK, Determination 
of 1-phenyl-3-methyl-5-pyrazolone-labeled carbohydrates by 
liquid chromatography and micellar electrokinetic 
chromatography, Journal of Chromatogr B, 2003;793:159–
165. 
18. Koller M, Bona R, Hermann C, Horvat P, Martinz J, Neto J, 
Varila P,  Braunegg G,  Biotechnological production of poly (3-
hydroxybutyrate) with Wautersia eutropha by application of 
green grass juice and silage juice as additional complex 
substrates. Biocatal. Biotransform, 2005; 23: 329-337. 
19. Sayyed RZ, Gangurde NS, Chincholkar SB, Hypochlorite 
digestion method for efficient recovery of PHB from 
Alcaligenes faecalis. Indian Journal of Microbiology, 2009; 49: 
230-232. 
20. Law JH, Slepecky RA, Assay of poly-β-hydroxybutric acid. 
Journal of Bacteriology, 1961; 82(1): 33-36. 
21. Kato M, Bao HJ, Kang CK, Fukui T, Doi Y, Production of a novel 
copolyester of 3-hydroxybutyric acid and medium-chain-
length 3- hydroxyalkanoic acids by Pseudomonas sp. 61-3 
from sugars, Applied Microbiology and Biotechnology, 1996; 
45:363-370. 
22. Bazzo GC, Lemos-Senna E, Goncalves MC, Pires  ATN, Effect of 
preparation conditions on morphology, drug content and 
release profiles of poly(hydroxybutyrate) microparticles 
containing piroxicam, Journal of the Brazilian Chemical 
Society, 2008; 19( 5): 914-921. 
23. Taghavi S, Garafola C, Monchy S, Lee M, Hoffman A, Weyens N, 
Barac T, Jaco V, van der Lelie D, Genome survey and 
characterization of entophytic bacteria exhibiting a beneficial 
effect on growth and development of poplar trees. Applied 
Environmental Microbiology, 2009; 75: 748–757. 
24. Le Meur S, Zinn M, Egli T, Thony-Meye, L, Ren Q, Production of 
mediumchain-length polyhydroxyalkanoates by sequential 
feeding of xylose and octanoic acid in engineered 
Pseudomonas putida KT2440. BMC Biotechnology, 2012; 
12:53. 
25. Kulpreecha S, Boonruangthavorn A, Meksiriporn B, Thongchul 
N, Inexpensive fed-batch cultivation for high Poly (3-
Hydroxybutyrate) production by a new isolate Bacillus 
megaterium. Journal of Bioscience and Bioengineering, 2009; 
107: 240-245. 
26. Ma L, Zhang H, Liu Q, Chen J, Zhang J, Chen GQ, Production of 
two monomer structures containing medium-chain-length 
polyhydroxyalkanoates by β-oxidation-impaired mutant of 
Pseudomonas putida KT2442. Bioresource Technology, 2009; 
100:4891-4894. 
27. Vishnuvardhan RS, Thirumala M, Mahmood S, Production of 
PHB and P (3HB-co-3HV) biopolymers by Bacillus megaterium 
strain OU303A isolated from municipal sewage sludge, World 
Journal of Microbiology and Biotechnology, 2009; 25:391-397. 
28. Hahn SK, Chang YK, Kim BS, Chang HN, Optimization of 
microbial Poly (3hydroxybutyric Acid) recovery using 
dispersions of sodium hypochlorite solution and chloroform. 
Biotechnology and Bioengineering, 1994; 44:256-261.  
29. Sudesh K, Abe H, Doi Y, Structure and properties of 
polyhydroxyalkanoate, biological polyesters. Progress in 
Polymer Science, 2000; 25(10): 1503-1533.  
30. Williams S, Martin D, Applications of Polyhydroxyalkanoate 
(PHA) in medicine and pharmacy, Biopolymers, 2005; 91-103.  
31. Tripathi AD, Joshi TR, Srivastava SK,  Darani KK, Shankar 
Khade S, Srivastava J,  Effect of nutritional supplements on 
bioplastics (PHB) production utilizing sugar refinery waste 
with potential application in food packaging, Preparative 
Biochemistry Biotechnology, 2019; 49(6):567-577.  
32. Chaijamrus S, Udpuay N,  Production and characterization of 
Polyhydroxybutyrate from molasses and corn steep liquor 
produced by Bacillus megaterium ATCC 6748, Agricultural 
Engineering International: the CIGR E. journal. Manuscript FP, 
2008; 10:1-12. 
33. Astra LI, Hammond R, Tarakji K, Stephenson LW, 
Doxourbibin-induced canine CHF: advantages and 
disadvantages, Journal of Cardiac Surgery, 2003; 18(4): 301-
306. 
34. Fresta M, Puglisi G, Giammona G, Cavallaro G, Micali N, Furneri 
PM, Pefloxacine mesilate- and ofloxacin-loaded 
polyethylcyanoacrylate nanoparticles: characterization of the 
colloidal drug carrier formulation, Journal of Pharmaceutical 
Science, 1995; 84 (7): 895- 902.  
35. Govender T,  Riley T, Ehtezazi T, Garnett MC, Stolnik S, Illum L, 
Davis SS, Defining the drug incorporation properties of PLA–
PEG nanoparticles, International Journal of Pharmaceutics, 
2000; 199 (1):95–110.  
36. Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar 
V, Solid-state solubility influences encapsulation and release 
of hydrophobic drugs from PLGA/PLA nanoparticles, Journal 
of Pharmaceutical Science, 2004; 93 (7): 1804–1814. 
37. Kumari A, Yadav SK, Pakade YB, Singh B, Yadava SC, 
Development of biodegradable nanoparticles for delivery of 
quercetin. Colloids Surf B Biointerfaces, 2010; 80: 184–192. 
 
